학술논문
Su578 ANTI-FGFR1/KLB THERAPY IS ASSOCIATED WITH SHIFT IN OVERALL MICROBIOTA COMPOSITION AND INCREASED CAPACITY FOR SCFA PRODUCTION IN T2D
Document Type
Abstract
Author
Source
In Gastroenterology May 2021 160(6) Supplement:S
Subject
Language
ISSN
0016-5085